SFTPC and non-small cell lung carcinoma: Therefore, based on our and others’ research, we can hypothesize that overexpression of SFTPC upregulating SOX7 might directly activate SLIT2, and then inhibit the protein level of p-GSK3β(Ser9) in NSCLC cells.